According to Zhitong Finance App, Zhongguancun Technology Leasing (01601.HK) issued an announcement. On December 24, 2025, the company entered into a financial lease agreement II with tenant I (Zhejiang Shengzhao Pharmaceutical Technology Co., Ltd.). According to this, the lessor will purchase Tenant I's own leased asset II for a transfer price of RMB 40 million; and the lessor will lease the leased asset II back to Tenant I. The lease period is 48 months, and the total lease amount is approximately RMB 45.43 million. The leased asset II is pharmaceutical equipment. On December 24, 2025, the company entered into a financial lease agreement III with Tenant II (Jiangsu Shengzhao Pharmaceutical Co., Ltd.). According to this, the lessor will purchase Tenant II's own leased assets III for a transfer price of RMB 40 million; and the lessor will lease the leased assets III back to Tenant II for a period of 48 months, with a total lease amount of approximately RMB 45.43 million. The leased asset III is pharmaceutical equipment.

According to Zhitong Finance App, Zhongguancun Technology Leasing (01601.HK) issued an announcement. On December 24, 2025, the company entered into a financial lease agreement II with tenant I (Zhejiang Shengzhao Pharmaceutical Technology Co., Ltd.). According to this, the lessor will purchase Tenant I's own leased asset II for a transfer price of RMB 40 million; and the lessor will lease the leased asset II back to Tenant I. The lease period is 48 months, and the total lease amount is approximately RMB 45.43 million. The leased asset II is pharmaceutical equipment. On December 24, 2025, the company entered into a financial lease agreement III with Tenant II (Jiangsu Shengzhao Pharmaceutical Co., Ltd.). According to this, the lessor will purchase Tenant II's own leased assets III for a transfer price of RMB 40 million; and the lessor will lease the leased assets III back to Tenant II for a period of 48 months, with a total lease amount of approximately RMB 45.43 million. The leased asset III is pharmaceutical equipment.